Status: Not yet recruiting
Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures
The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.
Participants needed: 120
Trial details
Age: 60+Biological sex: AllType: ObservationalSponsor: SI-BONE, Inc.Updated: Apr 20, 2026
Eligibility criteria
≥ 60 years of age at screening [+7]
Any known anatomic issues that could prevent placement of iFuse TORQ TNT [+13]